Mostrando 10 resultados de: 10
Filtros aplicados
Subtipo de publicación
Article(10)
Clinical and epidemiological characterization of an outbreak by carbapenemase-producing klebsiella pneumoniae. January-March, 2017, Portoviejo, Ecuador
ArticleAbstract: Infection Control reported three cases of Kpn-KPC with a probable relation among them in the adult iPalabras claves:Colonized case, Epidemic outbreak, Infected case, Kpn-KPCAutores:Martha M. Fors-López, Milanés D., Silva E.Fuentes:scopusAssociation between arterial hypertension and modificable risk factors in subjects of the “la Bota” population Quito, 2017
ArticleAbstract: In Ecuador, arterial hypertension occupies the fourth place of mortality due to known diseases withPalabras claves:Hypertension, obesity, Physical activity, PREVALENCE, RISK FACTORSAutores:Martha M. Fors-López, Yadira PilataxiFuentes:scopusCOVID-19 infected patients in a Hemodialysis facility in Ecuador, 2020
ArticleAbstract: We retrospectively analyzed the data of 38 hemodialysis patients with COVID-19, including demographiPalabras claves:Clinical features, Coronavirus disease, covid-19, epidemiology, hemodialysisAutores:Berruz C., Caballero R., Elsa Bernal, Figueredo I., Fors E., Hernández M., MARTHA FORS, Martha M. Fors-López, Massuht F., Ramirez Y.Fuentes:googlescopusDepression: An experience of the Hospital for the Elderly, Quito, Ecuador, 2018
ArticleAbstract: The National Institute of Mental Health has revealed that approximately 15% of older adults have hadPalabras claves:Depression, Gijón test, Older adult, Yesavage testAutores:María Erazo, Martha M. Fors-LópezFuentes:scopusEvaluation of CIMAvaxEGF for the treatment of lung cancer: Meta-analysis of controlled clinical trials
ArticleAbstract: CIMAvaxEGF is a therapeutic cancer vaccine developed in Cuba and fully licensed in the country for uPalabras claves:EGF receptor, Epidermal growth factor, immunotherapy, Of non-small cell lung cancer vaccine therapy, Oncology vaccinesAutores:Aliuska Frías, Ballesteros J., Bárbara Wilkinson, Camilo Rodríguez, Carmen Elena Viada, Mabel Álvarez, Martha M. Fors-López, Neninger Vinageras E., Quintero J., Robaina M., Tania CrombetFuentes:scopusEvaluation of racotumomab for the treatment of lung cancer: Meta-analysis of controlled trials of the CIM
ArticleAbstract: Racotumomab is a therapeutic cancer vaccine entirely developed in Cuba and licensed in the country fPalabras claves:immunotherapy, Non-small cell lung cancer, Oncological vaccines, Racotumomab, Vaccinal treatmentAutores:Alfonso S., Aliuska Frías, Ballesteros J., Carmen Elena Viada, Hernández M., Mabel Álvarez, Macías A.E., Martha M. Fors-López, Quintero J., Robaina M.Fuentes:scopusOverview of tuberculosis coinfection with HIV in Ecuador 2010-2015
ArticleAbstract: To describe the behavior of Tuberculosis/Human Immunodeficiency Virus co-infection in a cohort of pePalabras claves:co-infection, human immunodeficiency virus, TuberculosisAutores:Cedeño M., Martha M. Fors-López, Pinargote R., Torres A.Fuentes:scopusSecurity 1E10 anti-idiotypic vaccine in patients with tumors of different locations
ArticleAbstract: Cancer is a leading cause of death in Cuba and the world. Lung cancer is the leading cause of death,Palabras claves:Anti-idiotypic, Breast, Cáncer, COLON, Non-small cell lung vaccine, security, Small cell lungAutores:Alfonso S., Carmen Elena Viada, García E., Guerra P.P., Hernández M., Macías A.E., MARTHA FORS, Martha M. Fors-López, Mendoza I.C., Neninger Vinageras E., Pérez Ruiz L., Santiesteban E.R., Vázquez A.M.Fuentes:googlescopusQuality of life assessment as a pbkp_redictor of survival in cancer
ArticleAbstract: The quality of life and survival are variables to take into account in the clinical trial of oncologPalabras claves:clinical trials, Oncology, quality of life, SurvivalAutores:Aliuska Frías, Ballesteros J., Bouza-Herrera C.N., Carmen Elena Viada, García L., Mabel Álvarez, Martha M. Fors-López, Ramos M., Santiesteban Y.Fuentes:scopusReport of a case with a reaction to polysulfone during hemodialysis. Reynadial Clinic, Guayaquil, 2020
ArticleAbstract: Hemodialysis (HD) treatment assumes a certain risk of adverse hypersensitivity reactions; cases of hPalabras claves:hemodialysis, Hypersensitivity reaction, Polysulfone membraneAutores:Caballero R., Elsa Bernal, Figueredo I., Fors E., Hernández M., Martha M. Fors-López, Massuht F., Ramirez Y.Fuentes:scopus